Cell-mediated immune response in the diseased joints in patients with reactive arthritis.

PubWeight™: 1.06‹?› | Rank: Top 15%

🔗 View Article (PMID 3012770)

Published in Scand J Immunol on June 01, 1986

Authors

Y T Konttinen, D Nordström, V Bergroth, M Leirisalo-Repo, B Skrifvars

Articles by these authors

Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group. Lancet (1999) 4.98

2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis (2011) 4.78

ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis (2005) 4.31

Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome. Ann Rheum Dis (1996) 3.68

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis (2009) 3.32

Tumor targeting with a selective gelatinase inhibitor. Nat Biotechnol (1999) 2.34

New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis (2009) 2.22

A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis. Rheumatology (Oxford) (2000) 2.19

Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study. Arthritis Rheum (1995) 2.16

Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. Arthritis Rheum (1991) 2.10

Only high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with "sawtooth" strategy. Ann Rheum Dis (1998) 2.09

Cardiovascular diseases in patients with rheumatoid arthritis. Scand J Rheumatol (2012) 2.03

Does arthroscopic acromioplasty provide any additional value in the treatment of shoulder impingement syndrome?: a two-year randomised controlled trial. J Bone Joint Surg Br (2009) 2.03

Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. Lab Invest (1998) 1.97

Recurrent aphthous ulcers today: a review of the growing knowledge. Int J Oral Maxillofac Surg (2004) 1.89

Antikeratin antibodies: diagnostic and prognostic markers for early rheumatoid arthritis. Ann Rheum Dis (1992) 1.86

Regulation of macrophage activation. Cell Mol Life Sci (2003) 1.83

Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-alpha and doxycycline. J Biol Chem (1997) 1.82

Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis. Ann Rheum Dis (2004) 1.76

Three month treatment of reactive arthritis with azithromycin: a EULAR double blind, placebo controlled study. Ann Rheum Dis (2004) 1.58

Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium. Arthritis Rheum (1997) 1.58

Vitamins A and E, retinol binding protein and zinc in rheumatoid arthritis. Clin Exp Rheumatol (1990) 1.57

Uveitis in young adults with juvenile idiopathic arthritis: a clinical evaluation of 123 patients. Ann Rheum Dis (2005) 1.54

Increased level of YKL-40 in sera from patients with early rheumatoid arthritis: a new marker for disease activity. Rheumatol Int (2001) 1.53

Sonographic analysis of enthesopathy in the lower extremities of patients with spondylarthropathy. Clin Exp Rheumatol (1994) 1.52

Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients. J Clin Periodontol (1996) 1.52

Identification of proteases from periodontopathogenic bacteria as activators of latent human neutrophil and fibroblast-type interstitial collagenases. Infect Immun (1992) 1.45

Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components. Ann Rheum Dis (1999) 1.44

Juvenile chronic arthritis in adult life: a study of long-term outcome in patients with juvenile chronic arthritis or adult rheumatoid arthritis. Clin Rheumatol (1999) 1.43

Bone regeneration and stem cells. J Cell Mol Med (2011) 1.41

Localisation of lysozyme mRNA in rheumatoid synovial membrane by in situ hybridisation. Ann Rheum Dis (1989) 1.40

Inhibitory effect of cephalothin on matrix metalloproteinase activity around loose hip prostheses. Antimicrob Agents Chemother (1996) 1.40

Campylobacter-triggered reactive arthritis: a population-based study. Rheumatology (Oxford) (2002) 1.38

Blood vessels of human islets of Langerhans are surrounded by a double basement membrane. Diabetologia (2008) 1.37

Gold nephropathy prototype of membranous glomerulonephritis. Am J Pathol (1974) 1.35

Doxycycline inhibits neutrophil (PMN)-type matrix metalloproteinases in human adult periodontitis gingiva. J Clin Periodontol (1995) 1.35

Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus. Lancet (1993) 1.34

Aggressive granulomatous lesions associated with hip arthroplasty. Immunopathological studies. J Bone Joint Surg Am (1990) 1.34

Annual incidence of inflammatory joint diseases in a population based study in southern Sweden. Ann Rheum Dis (2002) 1.32

Cellular immunohistopathology of acute, subacute, and chronic synovitis in rheumatoid arthritis. Ann Rheum Dis (1985) 1.30

Neuropeptides in synovium of patients with rheumatoid arthritis and osteoarthritis. J Rheumatol (1988) 1.29

Aggressive granulomatous lesions in cementless total hip arthroplasty. J Bone Joint Surg Br (1990) 1.24

Gastro-intestinal disturbances in patients with severe rheumatoid arthritis. Acta Med Scand (1970) 1.24

Specificity of the anticollagenase action of tetracyclines: relevance to their anti-inflammatory potential. Antimicrob Agents Chemother (1992) 1.23

Antibodies against cyclic citrullinated peptide (CCP) and levels of cartilage oligomeric matrix protein (COMP) in very early arthritis: relation to diagnosis and disease activity. Scand J Rheumatol (2004) 1.21

MMPs, IL-1, and TNF are regulated by IL-17 in periodontitis. J Dent Res (2007) 1.21

The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximab. Clin Exp Rheumatol (2011) 1.19

Reactive arthritis following an outbreak of Salmonella infection in Finland. Br J Rheumatol (1994) 1.19

Synovial lining, endothelial and inflammatory mononuclear cell proliferation in synovial membranes in psoriatic and reactive arthritis: a comparative quantitative morphometric study. Br J Rheumatol (1998) 1.19

Activation of type IV procollagenases by human tumor-associated trypsin-2. J Biol Chem (1997) 1.19

Finnish case-control and family studies support PTPN22 R620W polymorphism as a risk factor in rheumatoid arthritis, but suggest only minimal or no effect in juvenile idiopathic arthritis. Genes Immun (2005) 1.19

Immunohistochemical localization of Toll-like receptors 1-10 in periodontitis. Oral Microbiol Immunol (2008) 1.18

Reactive arthritis. Clin Rheum Dis (1985) 1.18

Sulfasalazine in the treatment of ankylosing spondylitis. A twenty-six-week, placebo-controlled clinical trial. Arthritis Rheum (1988) 1.18

Outcome in patients with early rheumatoid arthritis treated according to the "sawtooth" strategy. Arthritis Rheum (1996) 1.17

Characterization of the immunocompetent cells of rheumatoid synovium from tissue sections and eluates. Arthritis Rheum (1981) 1.17

Clinical, radiographic and MRI findings of the temporomandibular joint in patients with different rheumatic diseases. Int J Oral Maxillofac Surg (2006) 1.17

Production of tumour necrosis factor and interleukin 1 by monocytes of patients with previous Yersinia arthritis. Clin Exp Immunol (1988) 1.16

Evaluation of patients with rheumatoid cervical spine. Scand J Rheumatol (1987) 1.16

Pannus invasion and cartilage degradation in rheumatoid arthritis: involvement of MMP-3 and interleukin-1beta. Clin Exp Rheumatol (2005) 1.15

Osteolysis around total knee arthroplasty: a review of pathogenetic mechanisms. Acta Biomater (2013) 1.15

Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis. Ann Rheum Dis (2002) 1.14

Membranous glomerulonephritis in rheumatoid arthritis not related to gold or D-penicillamine therapy: a report of four cases and review of the literature. Clin Nephrol (1987) 1.13

The anticollagenolytic potential of lymecycline in the long-term treatment of reactive arthritis. Arthritis Rheum (1992) 1.13

Circulating immune complexes containing chlamydial lipopolysaccharide in acute myocardial infarction. Microb Pathog (1990) 1.13

A novel and simple immunocapture assay for determination of gelatinase-B (MMP-9) activities in biological fluids: saliva from patients with Sjögren's syndrome contain increased latent and active gelatinase-B levels. Matrix Biol (1998) 1.12

Cementless total replacement for old tuberculosis of the hip. J Bone Joint Surg Br (1988) 1.10

Regulation of the growth of Epstein-Barr virus-infected B cells. I. Growth regression by E rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8+ memory cells. J Immunol (1985) 1.10

Rapid proliferation of calcitonin gene-related peptide-immunoreactive nerves during healing of rat tibial fracture suggests neural involvement in bone growth and remodelling. Neuroscience (1993) 1.09

Combination drug therapy retards the development of rheumatoid atlantoaxial subluxations. Arthritis Rheum (2000) 1.09

Favourable social functioning and health related quality of life of patients with JIA in early adulthood. Ann Rheum Dis (2005) 1.09

Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions. Ann Rheum Dis (2009) 1.09

DNA synthesis in prolyl 4-hydroxylase positive fibroblasts in situ in synovial tissue. An autoradiography-immunoperoxidase double labeling study. J Rheumatol (1989) 1.08

Chlamydia pneumoniae as a triggering infection in reactive arthritis. Rheumatology (Oxford) (1999) 1.08

Progression of cervical spine changes in patients with early rheumatoid arthritis. J Rheumatol (1997) 1.08

Occipital headache in rheumatoid cervical facet joint arthritis. Lancet (1986) 1.08

Human neutrophil collagenase (MMP-8), identified in bronchiectasis BAL fluid, correlates with severity of disease. Chest (1995) 1.07

Reactive arthritis attributable to Shigella infection: a clinical and epidemiological nationwide study. Ann Rheum Dis (2004) 1.07

Association of autoantibodies to filaggrin with an active disease in early rheumatoid arthritis. Ann Rheum Dis (2001) 1.07

Occurrence of different ensuing triggering infections preceding reactive arthritis: a follow up study. Br Med J (Clin Res Ed) (1988) 1.06

[Antibiotic treatment in rheumatoid arthritis?]. Duodecim (1995) 1.06

Rheumatoid arthritis terminating in plasmocytoma. Acta Med Scand (1970) 1.06

Effects of tetracyclines on neutrophil, gingival, and salivary collagenases. A functional and western-blot assessment with special reference to their cellular sources in periodontal diseases. Ann N Y Acad Sci (1994) 1.06

MMP inhibition and downregulation by bisphosphonates. Ann N Y Acad Sci (1999) 1.05

Mast cell-derived tryptase in odontogenic cysts. J Oral Pathol Med (1996) 1.05

Matrix metalloproteinases, gelatinase and collagenase, in chronic leg ulcers. J Invest Dermatol (1996) 1.05

Immune response to polyglycolic acid implants. J Bone Joint Surg Br (1990) 1.05

Membrane components of Treponema denticola trigger proteinase release from human polymorphonuclear leukocytes. J Dent Res (1996) 1.04

Lymphocyte infiltrations of the gastric mucosa in Sjögren's syndrome. An immunoperoxidase study using monoclonal antibodies in the avidin-biotin-peroxidase method. Arthritis Rheum (1983) 1.03

Inflammatory involvement of cervical spine ligaments in patients with rheumatoid arthritis and atlantoaxial subluxation. J Rheumatol (1987) 1.03

No evidence of long-term benefits of arthroscopicacromioplasty in the treatment of shoulder impingement syndrome: Five-year results of a randomised controlled trial. Bone Joint Res (2013) 1.03